Chief Cushie ~MaryO~ Posted January 16, 2008 Chief Cushie Report Share Posted January 16, 2008 http://fdanews.com/newsletter/article?issu...rticleId=103156 RxTrials Institute Drug Pipeline Alert Jan. 16, 2008 | Vol. 6 No. 3 Ipsen, The Salk Institute Sign Strategic Research Agreement French drugmaker Ipsen and California's The Salk Institute for Biological Studies will sign a memorandum of understanding setting the framework for the creation of the Ipsen Life Sciences Program at The Salk Institute. Ipsen will provide funding for research programs in the field of proliferative diseases with a particular emphasis on novel therapeutic concepts for the treatment of pituitary adenomas, the company said. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.